Overall PTHL gets a fundamental rating of 2 out of 10. We evaluated PTHL against 35 industry peers in the Health Care Technology industry. While PTHL seems to be doing ok healthwise, there are quite some concerns on its profitability. PTHL does not seem to be growing, but still is valued expensively.

Quickly go to:

1. Profitability

2. Health

3. Growth

4. Valuation

5. Dividend

1. Profitability

1.1 Basic Checks

PTHL had negative earnings in the past year.

1.2 Ratios

PTHL has a Return On Assets of -47.18%. This is in the lower half of the industry: PTHL underperforms 71.43% of its industry peers.
PTHL's Return On Equity of -50.99% is in line compared to the rest of the industry. PTHL outperforms 45.71% of its industry peers.

		Industry Rank	Sector Rank
ROA	-47.18%
ROE	-50.99%
ROIC	N/A

ROA(3y)-6.25%

ROA(5y)N/A

ROE(3y)-24.78%

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

Looking at the Gross Margin, with a value of 82.90%, PTHL belongs to the top of the industry, outperforming 85.71% of the companies in the same industry.
In the last couple of years the Gross Margin of PTHL has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for PTHL so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	82.9%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y0.39%

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

PTHL does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for PTHL has been increased compared to 1 year ago.
Compared to 1 year ago, PTHL has a worse debt to assets ratio.

2.2 Solvency

PTHL has an Altman-Z score of 22.83. This indicates that PTHL is financially healthy and has little risk of bankruptcy at the moment.
PTHL's Altman-Z score of 22.83 is amongst the best of the industry. PTHL outperforms 91.43% of its industry peers.
PTHL has a Debt/Equity ratio of 0.03. This is a healthy value indicating a solid balance between debt and equity.
PTHL has a Debt to Equity ratio (0.03) which is in line with its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.03
Debt/FCF	N/A
Altman-Z	22.83

ROIC/WACCN/A

WACC8.34%

2.3 Liquidity

PTHL has a Current Ratio of 11.69. This indicates that PTHL is financially healthy and has no problem in meeting its short term obligations.
PTHL's Current ratio of 11.69 is amongst the best of the industry. PTHL outperforms 97.14% of its industry peers.
A Quick Ratio of 11.36 indicates that PTHL has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 11.36, PTHL belongs to the best of the industry, outperforming 97.14% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	11.69
Quick Ratio	11.36

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

PTHL shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -228.06%.
PTHL shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -32.45%.
Measured over the past years, PTHL shows a very negative growth in Revenue. The Revenue has been decreasing by -13.92% on average per year.

EPS 1Y (TTM)-228.06%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-470.59%

Revenue 1Y (TTM)-32.45%

Revenue growth 3Y-13.92%

Revenue growth 5YN/A

Sales Q2Q%-67.93%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.